Inhibition of GPR40 protects MIN6 β cells from palmitate-induced ER stress and apoptosis

Journal of Cellular Biochemistry

Volumn 113, Issue 4, 2012, Pages 1152-1158

  Wu, Jinwei ^a   Sun, Peng ^a   Zhang, Xiaodong ^a   Liu, Hong ^a   Jiang, Hualiang ^a   Zhu, Weiliang ^a   Wang, Heyao ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; GPR40 ANTAGONIST; MIN6 CELLS; PALMITATE

Indexed keywords

G PROTEIN COUPLED RECEPTOR 40; PALMITIC ACID; RECEPTOR ANTIBODY; RECEPTOR ANTIBODY DC260126; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; DOWN-REGULATION; ENDOPLASMIC RETICULUM; ISLETS OF LANGERHANS; MICE; PALMITIC ACID; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; SULFONAMIDES;

EID: 84863125612     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23450     Document Type: Article

References (45)

1. Abaraviciene SM, Lundquist I, Galvanovskis J, Flodgren E, Olde B, Salehi A,. 2008a. Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms. Plos One 3: e2182.
2. Abaraviciene SM, Lundquist I, Salehi A,. 2008b. Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities. Cell Mol Life Sci 65: 2256-2265.
3. Akerfeldt MC, Howes J, Chan JY, Stevens VA, Boubenna N, McGuire HM, King C, Biden TJ, Laybutt DR,. 2008. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 57: 3034-3044.
4. Araki E, Oyadomari S, Mori M,. 2003. Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood) 228: 1213-1217.
5. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, Murdock PR, Sauls HR, Jr, Shabon U, Spinage LD, Strum JC, Szekeres PG, Tan KB, Way JM, Ignar DM, Wilson S, Muir AI,. 2003. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278: 11303-11311.
6. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR, McCoy DC, Kenakin TP, Andrews JL, Ammala C, Fornwald JA, Ignar DM, Jenkinson S,. 2006. Pharmacological regulation of insulin secretion in MIN6cells through the fatty acid receptor GPR40: Identification of agonist and antagonist small molecules. Br J Pharmacol 148: 619-628.
7. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC,. 2003a. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110.
8. Butler AE, Janson J, Soeller WC, Butler PC,. 2003b. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: Evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52: 2304-2314.
9. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG,. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50: 1771-1777.
10. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL,. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes 54 (Suppl. 2): S97-S107.
11. Cnop M, Ladriere L, Igoillo-Esteve M, Moura RF, Cunha DA,. 2010. Causes and cures for endoplasmic reticulum stress in lipotoxic beta-cell dysfunction. Diabetes Obes Metab 12 (Suppl. 2): 76-82.
12. Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E, Overbergh L, Mathieu C, Lupi R, Hai T, Herchuelz A, Marchetti P, Rutter GA, Eizirik DL, Cnop M,. 2008. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 121: 2308-2318.
13. Diakogiannaki E, Morgan NG,. 2008. Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic beta-cell. Biochem Soc Trans 36: 959-962.
14. Donath MY, Halban PA,. 2004. Decreased beta-cell mass in diabetes: Significance, mechanisms and therapeutic implications. Diabetologia 47: 581-589.
15. Flodgren E,. 2007. The free fatty acid receptor GPR40-expression and role in islet hormone secretion. Lund University, Faculty of Medicine Doctoral Dissertation 2007:48, p 106.
16. Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF,. 2010. Lipid-induced pancreatic {beta}-cell dysfunction: Focus on in vivo studies. Am J Physiol Endocrinol Metab 300: E255-E262.
17. 2+ homeostasis in beta-cells. Am J Physiol Endocrinol Metab 296: E690-E701.
18. Harding HP, Ron D,. 2002. Endoplasmic reticulum stress and the development of diabetes: A review. Diabetes 51 (Suppl. 3): S455-S461.
19. Harding HP, Calfon M, Urano F, Novoa I, Ron D,. 2002. Transcriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol 18: 575-599.
20. Hu H, He LY, Gong Z, Li N, Lu YN, Zhai QW, Liu H, Jiang HL, Zhu WL, Wang HY,. 2009. A novel class of antagonists for the FFAs receptor GPR40. Biochem Biophys Res Commun 390: 557-563.
21. Itoh Y, Hinuma S,. 2005. GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion. Hepatol Res 33: 171-173.
22. Kahn SE,. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46: 3-19.
23. Kahn SE, Hull RL, Utzschneider KM,. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
24. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A,. 2006. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147: 3398-3407.
25. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ,. 2007. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50: 752-763.
26. Lee MS, Chang I, Kim S,. 2004. Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 83: 82-92.
27. Lei X, Zhang S, Bohrer A, Ramanadham S,. 2008. Calcium-independent phospholipase A2 (iPLA2 beta)-mediated ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) and mitochondria during ER stress-induced insulin-secreting cell apoptosis. J Biol Chem 283: 34819-34832.
28. Lupi R, Del Prato S,. 2008. Beta-cell apoptosis in type 2 diabetes: Quantitative and functional consequences. Diabetes Metab 34 (Suppl. 2): S56-S64.
29. Martinez SC, Tanabe K, Cras-Meneur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA,. 2008. Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57: 846-859.
30. Minami K, Yano H, Miki T, Nagashima K, Wang CZ, Tanaka H, Miyazaki JI, Seino S,. 2000. Insulin secretion and differential gene expression in glucose-responsive and -unresponsive MIN6 sublines. Am J Physiol Endocrinol Metab 279: E773-E781.
31. Oyadomari S, Mori M,. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389.
32. Robertson RP, Harmon J, Tran PO, Poitout V,. 2004. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 (Suppl. 1): S119-S124.
33. Sachdeva MM, Claiborn KC, Khoo C, Yang J, Groff DN, Mirmira RG, Stoffers DA,. 2009. Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress. Proc Natl Acad Sci USA 106: 19090-19095.
34. Schnell S, Schaefer M, Schofl C,. 2007. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol Cell Endocrinol 263: 173-180.
35. Schroder M,. 2008. Endoplasmic reticulum stress responses. Cell Mol Life Sci 65: 862-894.
36. Shimabukuro M, Zhou YT, Levi M, Unger RH,. 1998. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci USA 95: 2498-2502.
37. Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H,. 2005. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1: 245-258.
38. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW,. 2009. Beta cell apoptosis in diabetes. Apoptosis 14: 1389-1404.
39. Thomas SE, Dalton LE, Daly ML, Malzer E, Marciniak SJ,. 2010. Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev 26: 611-621.
40. Thorn K, Bergsten P,. 2010. Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6cells exposed to oleate compared to palmitate. J Cell Biochem 111: 497-507.
41. Tsujihata Y, Ito R, Suzuki M, Harada A, Negoro N, Yasuma T, Momose Y, Takeuchi K,. 2011. TAK-875, an orally available GPR40/FFA1 agonist enhances Glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. J Pharmacol Exp Ther 339: 228-237.
42. van der Kallen CJ, van Greevenbroek MM, Stehouwer CD, Schalkwijk CG,. 2009. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: Is there a role for adipose tissue and liver? Apoptosis 14: 1424-1434.
43. 2+ release through the c-Jun N-terminal kinase pathway. Mol Cell Biochem 324: 183-190.
44. Yang M, Chisholm JW, Soelaiman S, Shryock JC,. 2010. Sulfonylureas uncouple glucose-dependence for GPR40-mediated enhancement of insulin secretion from INS-1E cells. Mol Cell Endocrinol 315: 308-313.
45. Zhang X, Yan G, Li Y, Zhu W, Wang H,. 2010. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats. Biomed Pharmacother 64: 647-651.